HROW
Harrow Health Inc
33.10$
-0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 65.8% | 53.6% | 49.3% | 50.4% | 39.9% | 32.7% | 29.6% | 25.1% | 28.7% | 30.4% | 24.7% | 24.9% | |
| 34.2% | 46.4% | 50.7% | 49.6% | 60.1% | 67.3% | 70.4% | 74.9% | 71.3% | 69.6% | 75.3% | 75.1% | |
| 14.3% | 3.4% | 3.7% | 1.5% | 2.0% | 4.1% | 4.9% | 15.3% | 3.4% | 5.1% | 6.1% | 4.7% | |
| 487.2% | 128.7% | 88.1% | 67.1% | 70.7% | 64.7% | 0.1% | 57.0% | 65.7% | 63.8% | 64.7% | 56.2% | |
| 645.4% | 199.0% | 128.8% | 95.0% | 72.7% | 76.6% | 69.6% | 72.6% | 69.2% | 69.2% | 70.9% | 60.9% | |
| -611.3% | -152.6% | -79.6% | -45.4% | -12.6% | -9.4% | 0.8% | 2.2% | 2.2% | 0.3% | 4.4% | 14.2% | |
| 0.2% | 11.5% | 14.0% | 11.3% | 6.6% | 4.9% | 4.6% | 7.5% | 8.2% | 16.4% | 11.4% | 8.9% | |
| -609.5% | -163.6% | -96.3% | -48.3% | 35.3% | -0.2% | -7.0% | -24.7% | -15.8% | -18.2% | -8.7% | -0.6% | |
| -1.7% | 11.1% | -0.6% | -3.5% | -47.0% | 0.0% | 0.0% | 0.2% | 0.1% | 0.5% | 0.1% | 1.3% | |
| -609.5% | -163.6% | -95.7% | -44.8% | 35.3% | 0.3% | -6.9% | -24.8% | -15.9% | -18.7% | -8.8% | -1.9% | |
| -606.1% | -146.3% | -71.1% | -38.8% | -8.2% | 3.7% | 5.4% | 7.0% | -4.4% | 9.2% | 11.1% | 15.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.